drugset / Trial / NCT00619918

Nebulized Hypertonic Saline for Bronchiolitis

NCT00619918

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to examine the effect of nebulized 3% hypertonic saline in the treatment of viral bronchiolitis. The investigators hypothesize that nebulized 3% saline will decrease rate of hospital admission, decrease clinical severity scores, and decrease length of stay.

Timeline

Start
2008-02
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium chloride Unknown 3 % Inhaled
Subject sodium chloride Unknown 4 ml Inhaled

Indications